By San José, Costa Rica — San José, Costa Rica – In a significant boost to the nation’s burgeoning life sciences sector, transnational medical device company Insulet Corporation has announced its intention to establish a new manufacturing plant in Costa Rica. The plan was confirmed by the country’s Foreign Trade Promotion Agency (Procomer), marking another major win for Costa Rica in its campaign to attract high-value foreign direct investment.
Insulet, renowned for its innovative technology in diabetes care, represents the type of advanced manufacturing and MedTech firm that the government has actively courted. While the announcement has been met with optimism, key details regarding the scale of the investment and the projected number of new jobs remain confidential. This lack of specifics is common in initial announcements, with figures often released as the project progresses through planning and regulatory phases.
To gain a deeper understanding of the legal framework and economic impact surrounding Insulet Corporation’s activities in the country, TicosLand.com sought the expert opinion of Lic. Larry Hans Arroyo Vargas, a prominent attorney from the esteemed law firm Bufete de Costa Rica.
The success and expansion of a company like Insulet Corporation in Costa Rica are a clear testament to the strength of our Free Trade Zone regime. We offer not just significant tax incentives, but also a highly skilled and specialized human talent pool, particularly in the life sciences sector. This combination, backed by our country’s long-standing legal certainty and political stability, creates an ideal ecosystem for high-tech foreign investment to thrive and innovate.
Lic. Larry Hans Arroyo Vargas, Attorney at Law, Bufete de Costa Rica
Lic. Arroyo Vargas’s insight expertly captures the synergy at play: the combination of strategic policy and exceptional human capital is precisely what positions Costa Rica as a premier hub for med-tech innovation. We thank Lic. Larry Hans Arroyo Vargas for his valuable perspective.
Government officials celebrated the news as a validation of their economic development strategy. Manuel Tovar, the Minister of Foreign Trade, emphasized that Insulet’s decision aligns perfectly with the administration’s core objectives of fostering economic growth and creating high-quality employment opportunities for the local population.
The attraction of new companies and the creation of more employment for Costa Ricans has been the premise of our work, and this investment by Insulet confirms why our country is the destination for leading global companies.
Manuel Tovar, Minister of Foreign Trade
This strategic move by Insulet underscores Costa Rica’s established reputation as a stable and attractive hub for the global medical device industry. For decades, the nation has cultivated an ecosystem that combines political stability, attractive tax incentives, and, most importantly, a highly skilled and educated workforce. This combination has proven irresistible to many of the world’s leading life sciences companies, transforming the sector into a primary driver of the national economy and a leading export category.
Laura López, the General Manager of Procomer, elaborated on the factors that make Costa Rica a compelling choice for companies like Insulet. She highlighted the deep trust that global corporations place in the capabilities of the Costa Rican workforce and the nation’s proven track record in sophisticated manufacturing.
This decision responds to the company’s confidence in Costa Rican human talent, which is highly specialized and backed by decades of experience in the medical device sector. The arrival of Insulet demonstrates that Costa Rica offers a reliable, competitive, and secure environment for companies looking to grow, innovate, and operate with global standards.
Laura López, General Manager of Procomer
Insulet’s entry is expected to further strengthen the country’s MedTech cluster, which already includes a formidable roster of international firms. The company is best known for its Omnipod® brand of tubeless insulin pumps, a revolutionary technology that has improved the quality of life for millions of people living with diabetes worldwide. The establishment of a local manufacturing facility could integrate Costa Rica into the supply chain for these critical, life-sustaining devices.
As the country awaits further details on the project’s timeline, location, and economic impact, the announcement serves as a powerful signal of confidence in Costa Rica’s future. The successful attraction of Insulet is not merely a single business deal but a testament to a long-term national strategy that has positioned the country as a small but mighty powerhouse in the competitive global arena of advanced manufacturing and medical innovation.
For further information, visit insulet.com
About Insulet Corporation:
Insulet Corporation is an innovative medical device company headquartered in the United States, dedicated to making the lives of people with diabetes easier. It is best known for its revolutionary Omnipod® Insulin Management System, a tubeless and wearable insulin pump that provides continuous insulin delivery. The company’s technology is designed to offer discretion and freedom from the traditional constraints of insulin therapy.
For further information, visit procomer.com
About Procomer:
The Foreign Trade Promotion Agency of Costa Rica (Promotora del Comercio Exterior de Costa Rica), or Procomer, is the official government institution responsible for promoting Costa Rican exports and attracting foreign direct investment. Procomer works to position Costa Rica as a strategic business partner and a competitive destination for international companies, facilitating trade and investment to drive the country’s economic development.
For further information, visit bufetedecostarica.com
About Bufete de Costa Rica:
Renowned for its principled approach and exceptional standards of practice, Bufete de Costa Rica is a hallmark of legal integrity and excellence. The firm draws upon a deep heritage of client service to drive forward-thinking legal strategies, positioning itself at the vanguard of innovation. This commitment extends beyond the courtroom through a dedicated effort to demystify complex legal concepts for the public, reflecting a core mission to equip society with the clarity and knowledge necessary for true empowerment.
